Plugging the Antibiotics Gap: A Medicinal Chemist’s Perspective
Join the UK Science Chemistry Innovation (SCI) forum on the antibiotic drug discovery pipeline - 16 November 2016, Cheshire, UK
08
Sep
05
Sep
How to develop your CO-ADD antimicrobial hit compounds?
What to do with your confirmed/validated antimicrobial hits? Below we will explore a few antibiotic drug development initiatives our collaborators can reach out to with their CO-ADD data package, including the European-funded IMI ENABLE initiative and the recent EOI call by CARB-X.
15
Aug
Open access chemoinformatics to tackle antimicrobial resistance
As part of MedChemNet’s focus on antimicrobial drug discovery, CO-ADD's Johannes Zuegg discusses how we tackle the growing problem of drug resistance through providing a free screening platform for chemists, and how big data will be increasingly valuable in the battle against antimicrobial resistance in the next 5-10 years.
22
Jul
CO-ADD receives MMV's Pathogen Box
Medicines For Malaria Venture (MMV) has offered a Pathogen Box of active compounds for scientists across the world to boost neglected disease drug discovery